Correlation Between Verve Therapeutics and Dianthus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verve Therapeutics and Dianthus Therapeutics, you can compare the effects of market volatilities on Verve Therapeutics and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Dianthus Therapeutics.

Diversification Opportunities for Verve Therapeutics and Dianthus Therapeutics

0.61

Correlation Coefficient

Verve Therapeutics  Dianthus Therapeutics

Poor diversification

The 3 months correlation between Verve and Dianthus is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Dianthus Therapeutics go up and down completely randomly.

Pair Corralation between Verve Therapeutics and Dianthus Therapeutics

Given the investment horizon of 90 days Verve Therapeutics is expected to generate 3.11 times more return on investment than Dianthus Therapeutics. However, Verve Therapeutics is 3.11 times more volatile than Dianthus Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Dianthus Therapeutics is currently generating about 0.05 per unit of risk. If you would invest  422.00  in Verve Therapeutics on May 7, 2025 and sell it today you would earn a total of  691.00  from holding Verve Therapeutics or generate 163.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	90.32%
Values	Daily Returns

Verve Therapeutics  vs.  Dianthus Therapeutics

Verve Therapeutics

Risk-Adjusted Performance

Good

Over the last 90 days Verve Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly unsteady basic indicators, Verve Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Dianthus Therapeutics

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Dianthus Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Dianthus Therapeutics may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with Verve Therapeutics and Dianthus Therapeutics

The main advantage of trading using opposite Verve Therapeutics and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.

The idea behind Verve Therapeutics and Dianthus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.